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Chemical sensitivity in humans may be an acquired disorder in which individuals become
increasingly sensitive to chemicals in the environment. It is hypothesized that in individuals with
multiple chemical sensitivity (MCS), a sensitization process has occurred that is akin to behavioral
sensitization and kindling observed in rodents. In the rodent sensitization model, repeated
exposure to stress or drugs of abuse enhances behavioral and neurochemical responses to
subsequent stimuli (stress or drugs of abuse). Kindling is a form of sensitization in which repeated
application of electrical stimuli applied to the brain at low levels culminates in the induction of full-
blown seizures when the same stimulus is applied at a later time. A similar sensitization of
specific limbic pathways in the brain may occur in individuals with MCS. The time-dependent
nature of sensitization and kindling and the role of stress in the development of sensitization are
discussed in the context of rodent models, with an emphasis on application of these models to
human studies of MCS. Environ Health Perspect 105(Suppl 2):467-471 (1997)
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Introduction
Chemical sensitivity is an ill-defined
disorder occurring in a subset ofthe human
population that has been attributed to expo-
sure to chemicals, usually volatile organic
compounds. Individuals who develop sensi-
tivity to chemicals report an array ofsymp-
toms involving the central nervous system
(CNS) and other organ systems; among the
symptoms are fatigue, depression, head-
aches, gastrointestinal problems, muscle and
joint pain, irritability, memory and concen-
tration difficulties, and many others (1,2).
Although a case definition for chemical
sensitivities, often referred to as multiple
chemical sensitivity or MCS, has not been
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agreed upon, a common feature ofchemi-
cal sensitivity is found among individuals
experiencing symptoms as a result ofexpo-
sures at various sites. Such individuals
include GulfWar veterans (GulfWar syn-
drome), industrial workers, and those living
near hazardous waste sites. MCS is pur-
ported to occur after single, high-dose expo-
sures (such as chemical spills) or repeated
low-level exposures to chemicals (1).The
existence ofMCS has aroused much contro-
versy which stems largely from several fac-
tors: the inability to rigorously identify true
sensitivities to chemicals because of the
unreliability ofself-reports linking illness to
chemical exposure; the diversity of symp-
toms and their overlap with those ofother
illnesses, such as somatoform disorder,
chronic fatigue syndrome, fibromyalgia,
panic disorder, and posttraumatic stress dis-
order (PTSD); and the possibility offalsely
attributing symptoms from other illnesses to
chemical exposure (3-9). Typically, individ-
uals with MCS complain ofill effects from
chemicals present in very low concentrations
in the environment, suggesting that a possi-
ble amplification has occurred in the
processes involved with either the perception
ofillness from chemicals or other effects of
these compounds on the system.
Identification of potential triggering
mechanisms in the development ofthis dis-
order is critical to a greater understanding
of MCS. Since MCS appears to develop
because of exposure to a wide variety of
chemicals, it is likely that MCS is a result
of a common neurological disorder rather
than a manifestation ofdistinct pathologies
specific to each chemical. The limbic sys-
tem integrates environmental stimuli into
behavioral output, and may be responsible
for the wide array ofsymptoms reported by
individuals with MCS. Bell et al. (10) have
proposed that MCS symptoms result from
a sensitization process occurring in specific
limbic regions ofthe CNS and hypothesize
that limbic kindling and/or sensitization in
rodents may provide an appropriate model
system for MCS studies. Several features of
sensitization appear to parallel those of
MCS, including the progressive increase in
sensitivity to drugs and chemicals (10,11),
the apparent permanence of sensitivity
(1,12), the greater sensitivity of females
than males (13,14), and the spreading of
sensitization in response to stimuli other
than the initial stimulus used to induce
sensitization (as with cross-sensitization
between psychostimulants and stress)
(14,15). This paper addresses the potential
involvement ofstress and temporal changes
in the development ofMCS with analogies
to behavioral sensitization and kindling
in rodents.
Sensitization/Kindling
Sensitization in rodents refers to the
progressive and enduring increase in behav-
ioral (usually locomotion or stereotyped
movements) or neurochemical responses
after repeated exposure to stress or drugs of
abuse. Sensitization in rodents serves as an
animal model for drug-induced psychosis,
panic disorder, and PTSD. Kindling is a
form of sensitization in which repeatedly
presented electrical stimuli to the brain
(usually the amygdala) that initially do not
produce seizures can, with the passage of
time, produce full-blown seizures in
response to the same level ofstimulus (16).
Both behavioral sensitization by psycho-
stimulants or stress and kindling result in
increased responsiveness ofthe organism to
stimuli with the passage of time. Although
kindling is described as a subtype ofsensiti-
zation in the general sense, the relationship
between behavioral sensitization induced by
psychostimulants or stress and electrical
kindling is unclear. There is much evidence
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for a cocaine kindling phenomenon in
which seizures induced by cocaine are
observed with increased frequency in ani-
mals administered cocaine repeatedly (17).
To determine if electrically induced kin-
dling and psychostimulant-induced sensiti-
zation share common neural substrates,
repeated psychostimulants have been
administered and subsequent effects on the
kindling process examined. Some studies
have failed to find any effects ofdrug pre-
treatment on kindling (18,19), whereas
repeated methamphetamine has been
reported to lower the seizure threshold
(20). The anticonvulsant, carbamazepine,
which blocks electrical kindling once
established (21), also decreases the devel-
opment of cocaine-kindled seizures but
does not block the development ofbehav-
ioral sensitization to cocaine (22). More
recently, Schenk and Snow (23) con-
ducted an experiment to address the con-
verse question of whether electrical
kindling potentiated the effect ofcocaine-
induced locomotor activity. Electrical kin-
dling of the medial prefrontal cortex
(limbic cortex), but not the hippocampus,
produced behavioral sensitization to
cocaine. Thus, differing effects may be
obtained depending on which brain region
has been electrically stimulated. Additional
studies suggest that one potential overlap
between cocaine sensitization, cocaine-kin-
dling, and electrical kindling occurs at the
N-methyl-D-aspartate (NMDA) glutamate
receptor subtype (21,24,25).
Role of Stress in
Sensitization/Kindling
and MCS
The effects ofstress on human health have
been apparent for several years (26).
However, whether life stressors can render
an individual more susceptible to develop
illnesses from chemical exposures and ulti-
mately produce MCS is unknown. Bell et
al. (27) have shown that stress may be a
factor contributing to the onset of MCS.
Symptoms ofMCS involve several systems,
including the autonomic, immune and
endocrine systems (28), which can be
modulated by stress. Because the brain reg-
ulates endocrine, autonomic, and immune
system function, stress effects on the CNS
must be considered potential predisposing
factors to MCS.
Stress has a great impact on the
development and expression ofbehavioral
sensitization in rodents. Sensitization
studies over the past 15 years have described
a cross-sensitization ofstress and drugs of
abuse (15). In such a cross-sensitization
paradigm, repeated stress is administered to
rodents, resulting in augmentation of
behavioral and neurochemical measures in
response to subsequent drug exposure.
Thus, environmental stress can replace
repeated psychostimulant administration,
altering the same pathways utilized for
expressing sensitization.
The role of environmental stress in
enhancing susceptibility to kindling or
vice-versa is unclear at present. The
increase in anxiety levels produced by
amygdala kindling (29) can be reversed by
an environmental stressor (saline injection)
or by corticotropin-releasing hormone
(CRH), a stress-induced hormone (30),
suggesting that anxiety induced by kin-
dling can be countered by stress. On the
other hand, additional studies have exam-
ined whether CRH or glucocorticoids,
both ofwhich increase after stressful stim-
uli, alter the course ofelectrical kindling.
Cocaine kindling is enhanced by CRH
administration (31), and glucocorticoids
enhance CRH-induced seizures (32).
Other stressors such as prenatal stress and
social conflict indicate a complex relation
between stress and seizure activity. The
effect ofprenatal stress on convulsant drug-
induced seizures depends on the develop-
mental stage during which stress is applied
(33). The development of the kindling
process has been shown to be altered differ-
ently by the outcome ofconflict stress, i.e.,
whether the conflict resulted in victory or
defeat (34). When all the studies to date
regarding the neural substrates involved in
psychostimulant/stress-induced sensitiza-
tion and kindling are considered, there
appears to be some overlap. Additional
studies examining the effects ofchemicals
using animal models are necessary to deter-
mine if one or both of these models best
describe the mechanisms mediating the
onset and/or progression of chemical
sensitivity in humans.
In addition to the influence ofenviron-
mental factors such as stress, it is likely that
genetic factors may predispose individuals
to develop MCS. The suggestion that
chronic stress may be a predisposing factor
in MCS allows one to speculate that MCS
onset in relatively stress-free individuals is
due to existing alterations in those specific
pathways affected by chronic stress. For
example, the expression of a vast array of
genes in the CNS is altered by exposure to
chronic stress (35). Individuals who may
have genetic predispositions to develop
MCS could exhibit similar alterations
in one or many of the genes normally
expressed only after chronic stress. Thus,
adaptive responses to further stress (includ-
ing chemicals) become maladaptive for the
organism because of a previous state of
altered gene expression.
Time-dependence of
Sensitization/Kindling
In individuals with MCS, chemicals are
believed to be the initiating (often referred
to as triggering) stimuli that after the pas-
sage oftime produce a wide array ofsymp-
toms when the same or often a different
and unrelated chemical is presented
(referred to as elicitation). Most reports
indicate that the onset ofMCS occurs long
after initial chemical exposure (often several
weeks or months), suggesting that time-
dependent mechanisms are involved in this
process. In behavioral sensitization and kin-
dling studies, the effects of repeated drug
or electrical stimuli presentation also pro-
gressively increase with the passage oftime.
Recent studies on behavioral sensitization
indicate a clear temporal and anatomical
distinction between events involved in ini-
tiation compared with those involved in
elicitation, or expression, of sensitization
(36). These studies indicate that a number
of transient changes occur in the midbrain
during the initiation phase ofsensitization;
these changes disappear by the time expres-
sion of sensitization is observed. These
transient changes are thought to trigger
permanent alterations in the forebrain that
are responsible for the expression ofsensiti-
zation. Similarly, various stages ofkindling
are associated with activation ofthe imme-
diate-early gene, c-fos, in different brain
regions depending on the stage ofkindling
(37). The concept that different phases of
sensitization and kindling exist is under-
scored by the differential responsiveness to
pharmacological manipulations during
each phase. For example, blocking of the
D2 dopamine receptor subtype prevents
conditioned behavioral sensitization to
cocaine if the cocaine is given during the
initiation phase; that is, just prior to each
daily drug injection. However, after initia-
tion events have been allowed to take place
in the absence of this antagonist, the
expression phase ofsensitization cannot be
prevented by D2 dopamine receptor block-
ade (38). The different phases ofkindling
also respond differentially to drugs (39).
These studies indicate that, as with
progressive chronic illnesses, there are dis-
crete stages through which the organism
advances as a consequence of several
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different biochemical/molecular changes
(39). The notion that many of these
changes are likely to be transient further
complicates the task ofdetermining physi-
ological end points that may serve as diag-
nostic criteria for MCS. As a first step
toward understanding the events that
follow the triggering ofMCS, it is impor-
tant to identify individuals exposed to a
particular chemical environment who are
synchronized in their initiation of MCS.
Longitudinal studies on workers involved
in a chemical spill or installment of new
carpeting in a building would serve as logi-
cal first steps toward understanding the
MCS phenomenon. Long-term continued
follow-up investigations should identify
alterations in physiological changes in all
exposed individuals (those who do and
those who do not develop MCS symp-
toms). Follow-up studies of non-MCS
individuals experiencing the same high-
level, short-term chemical exposures would
provide the control group with which to
compare changes reported by those who
develop MCS symptoms. The list ofphysi-
ological parameters that could be assessed
includes but is not limited to the following:
changes in heart rate and respiration, alter-
ations in neuroendocrine, electroen-
cephalography and electromyography
patterns, and a battery ofneuropsychologi-
cal tests for memory and attention
(10,40,41). Through several testing proce-
dures, a pattern ofchanges may emerge in
individuals who develop chemical sensitiv-
ity. Based on several reports, only a subpop-
ulation ofexposed individuals would be
expected to develop MCS symptoms as a
result of chemical exposure (responders),
whereas a larger percentage ofthe popula-
tion would not exhibit MCS symptoms
(nonresponders). It should be emphasized
that only the most rigorously executed
studies (e.g., those employing double-blind
chemical challenges) should be conducted
to gain knowledge about consistent changes
in the pattern ofphysiological responses.
Moreover, comparison of these patterns
with those ofsimilarly chemically exposed
individuals in the same workplace setting
not reporting chemical sensitivities is criti-
cal to identify relevant changes in physio-
logical and neuropsychological function
that may accompany MCS. Regular peri-
odic testing of these parameters in all
exposed subjects may be imperative to
identify pathological changes associated
with the initiation and progression ofMCS
compared with compensatory changes
that occur in all exposed individuals.
Compensatory changes are considered
adaptive responses that bring an individual's
system back to homeostasis, whereas patho-
logical changes are those that contribute to
the onset ofMCS.
Sensitization/Kindling
As a Model for MCS
The lack ofanimal models and treatment
strategies for MCS makes it difficult to
directly assess the goodness-of-fit between
sensitization/kindling phenomena and
MCS. However, some studies have demon-
strated that many chemicals implicated
in inducing MCS symptoms, including
pesticides and organic solvents, promote
seizures and/or kindling in limbic struc-
tures (42-44). A potential criticism of
using sensitization and kindling models to
mimic MCS in humans is that the levels of
electrical or drug stimulation exceed those
encountered by humans in the environ-
ment, especially when considering several
reports that suggest that long-term, low-
level chemical exposures produce MCS
symptoms (1). However, recent studies
have demonstrated long-term cross-sensi-
tization to the locomotor effects of the
dopamine agonist, apomorphine, in rats
exposed to subthreshold levels of toluene
for 1 month (45). Recent data from our
laboratory indicate that daily exposure to a
low level of formaldehyde (1.0 ppm) for
1 hr per day for 1 week does not induce a
cross-sensitization to cocaine-induced loco-
motion, but the same daily exposure for a
1-month period produces a robust sensiti-
zation of rearing behavior in response to
cocaine (Sorg et al., unpublished results).
These studies suggest that low-level, long-
term exposure can sensitize specific limbic
pathways. These same pathways long have
been thought to be associated with certain
human behaviors such as panic disorder and
psychoses as well as behavioral responses to
rewarding and aversive stimuli. Thus, the
data from these animal studies suggest that
the potential for altered limbic system
functioning in humans exists, whether at
the level ofamplified perception ofchemi-
cals or at other undetermined sites within
the CNS.
Since ageneral definition ofsensitization
is any increase in a neuronal response to a
stimulus, modeling MCS studies after sen-
sitization in animals may prove to be use-
ful, even ifthe fit is not a perfect one. In
spite of the observed similarities between
the onset of MCS and sensitization/kin-
dling, these rodent models cannot accu-
rately represent all aspects of MCS. It is
not plausible to develop an animal model
ofMCS based on the wide variety ofsymp-
toms experienced by chemically sensitive
humans, but a nonhomologous, mechanis-
tically based model may provide clues
about alterations in specific brain path-
ways. Thus, changes in the same neuro-
chemical pathways in animals as in humans
do not necessarily translate into similar
behavioral manifestations. One example of
this is the different behavioral outcomes in
rodents and humans following repeated
cocaine exposure; in the former, locomotor
activity is enhanced, in the latter, psychotic
symptoms develop. Both behaviors, how-
ever, are believed to be mediated by
amplification of limbic dopamine neuro-
transmission, and both behaviors are
blocked by dopamine receptor antagonists.
Eventually, treatments that could interfere
with the initiation or expression of sensiti-
zation and/or kindling in rodents may
prove beneficial in the development of
treatment strategies for MCS.
Summary and
Future Directions
Two major issues should be considered
in designing animal and human studies.
First, the time-dependent changes that
occur in response to a demonstrable chemi-
cal exposure should be taken into account.
Investigating individuals chemically exposed
within a relatively narrow window of time
would increase the likelihood of testing
individuals who are in similar stages ofthe
progression ofMCS. Different underlying
physiological and neuropsychological
changes that accompany the transforma-
tion from early to later stages of MCS
may therefore be mapped more accu-
rately. Long-term testing of physiological
and neuropsychological parameters should
be conducted not only in individuals who
develop MCS (responders) but in all
exposed individuals (including nonre-
sponders who do not develop MCS symp-
toms). Measurements should begin at the
earliest time possible after a high-level,
short-duration exposure.
Second, the role ofstress in predisposing
individuals to the onset ofMCS should be
considered. Although self-reports of stress
and anxiety can be somewhat unreliable,
this should not preclude collection ofself-
reported levels ofprevious and current life
stressors. Animal studies designed to model
MCS should consider the role ofrepeated
stressful stimuli in predisposing the animal
to subsequent chemical-induced changes in
brain and behavior. For these particular
Environmental Health Perspectives - Vol 105, Supplement 2 - March 1997 469SORG AND PRASAD
studies, physiological stressors such as swim
stress, footshock, tailpinch, sleep or food
deprivation, maternal deprivation, and psy-
chological stressors such as conditioned
fear, should be administered during various
stages ofdevelopment (prenatal, neonatal,
adulthood) to determine ifprevious stress
or stress administered concurrently with
chemical exposure predisposes animals to
altered CNS function. Such alterations in
CNS functioning (46) could easily be
measured by monitoring behaviors such as
sensitization of locomotion/stereotypy to
psychostimulants, kindling development,
startle response, olfactory threshold, condi-
tioned and nonconditioned avoidance
responses to aversive stimuli (including
odors), memory tasks, and other complex
tasks requiring attention and response
sequences. These behavioral measures are
designed to assess changes in sensory,
motor, memory and cognitive functions.
Thus, examination ofthe effects ofrepeated
chemical exposure in animals on specific
behaviors mediated by brain pathways that
have already been well mapped provides a
starting point for understanding which
neural substrates maybe altered.
A final point should be made about the
use ofanimal models for a complex disorder
such as MCS. Alterations in CNS function-
ing ofanimals administered repeated chemi-
cal exposure do not formally prove that
MCS is a true disorder in humans, but any
alterations would lend strong support to the
potential for such alterations to take place in
the human CNS as well. Such findings
would warrant careful attention and further
rigorous investigation in humans.
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